Source comparison
GHRP-6 Acetate vs Other Growth Hormone Secretagogues: Research Comparison
Growth hormone secretagogues form a class that includes multiple structural families. GHRP peptides (GHRP-2, GHRP-6, Hexarelin), GHRH analogs (CJC-1295, Sermorelin, Tesamorelin), and non-peptide mimetics (MK-677/Ibutamoren). Each binds different receptors or r
This comparison does not assign a generated winner or score.
- Growth hormone secretagogues form a class that includes multiple structural families. GHRP peptides (GHRP-2, GHRP-6, Hexarelin), GHRH analogs (CJC-1295, Sermorelin, Tesamorelin), and non-peptide mimetics (MK-677/Ibutamoren). Each binds different receptors or receptor subtypes, producing distinct pharmacological profiles relevant to research design.
- GHRP-6 Acetate
- GHS-R1a (ghrelin receptor)
- High (dose-dependent)
- Moderate to strong increase
- 30–60 min
- Metabolic studies, tissue repair, synergy protocols
- Strong GH secretion with notable ghrelin-like appetite stimulation. Best when appetite effects are desired or neutral to the study
- GHRP-2
- Minimal
- Pure GH studies where appetite confounds must be avoided
- Similar GH response to GHRP-6 acetate but without appetite stimulation. Preferred when isolating GH effects
- Hexarelin
- Very high
- Minimal to moderate
- 60–90 min
- Cardioprotection studies, maximum GH stimulation
- Most potent GH secretagogue but shows receptor desensitization with chronic dosing. Not ideal for long-duration studies
- CJC-1295
- GHRH receptor
- Moderate to high (when pulsed)
- None
- 6–8 days (DAC version)
- Chronic GH elevation studies, synergy with GHRPs
- GHRH analog that extends GH pulse duration. Works synergistically with GHRP-6 acetate via different receptor pathway
- Sermorelin
- Moderate
- 8–12 min
- Acute GH response studies, diagnostic testing
- Short-acting GHRH analog. Must be dosed frequently or combined with a GHRP for sustained elevation
- MK-677 (Ibutamoren)
- Moderate sustained
- Strong increase
- 24 hours
- Long-duration studies, oral administration models
- Non-peptide ghrelin mimetic with oral bioavailability. Produces sustained GH elevation but strong appetite effects
- GHRP-6 acetate sits in the middle of the secretagogue spectrum. More GH output than Sermorelin alone, less receptor desensitization than Hexarelin, more appetite effect than GHRP-2. Research teams choose GHRP-6 acetate when they need reliable GH pulses without the complexity of continuous infusion but don't mind or actively want ghrelin receptor activation's metabolic effects.
- The synergy between GHRP-6 acetate and GHRH analogs is well-established in endocrinology literature. A study in the Journal of Clinical Endocrinology & Metabolism found that combining GHRP-6 acetate (1 mcg/kg) with GHRH (1 mcg/kg) produced mean GH peaks 3.8 times higher than GHRP-6 acetate alone and 2.1 times higher than GHRH alone. A true synergistic effect beyond simple addition. This is why CJC-1295/Ipamorelin stacks have become standard in protocols targeting maximum physiological GH elevation.